BrainsWay Ltd. (BWAY) Financials

BWAY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 112.9 million 34.7 million
Dec. 31, 2025 112.9 million 39.7 million
Sept. 30, 2025 113.1 million 43.0 million
June 30, 2025 111.6 million 43.4 million

BWAY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 518790 ?
Dec. 31, 2025 518790 280000
Sept. 30, 2025 585999 364000
June 30, 2025 11.2 million 227000

BWAY Net Income

No data available :(

BWAY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 69.1 million - -
Dec. 31, 2025 69.1 million - 6.8 million
Sept. 30, 2025 70.5 million - 6.8 million
June 30, 2025 78.0 million - 6.1 million

BWAY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 21.0 million
Dec. 31, 2025 21.0 million
Sept. 30, 2025 38.0 million
June 30, 2025 37.8 million

BWAY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.3 million 2.5 million - -
Dec. 31, 2025 1.3 million 2.5 million 6.7 million -
Sept. 30, 2025 800000 2.4 million 6.5 million 4.7 million
June 30, 2025 1.2 million 2.3 million 6.6 million 4.9 million

BWAY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 14.6 million 3.4 million
Dec. 31, 2025 14.6 million 3.4 million
Sept. 30, 2025 13.5 million 3.4 million
June 30, 2025 12.6 million 3.1 million

BWAY

Price: $13.98

52 week price:
5.11
17.35

Earnings Per Share: 0.22 USD

P/E Ratio: 67.64

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: Israel

Volume: 22800

Market Capitalization: 559.7 million

Links: